Supplemental Financial Information

3 Months Ended

Mar. 31, 2024

Supplemental Financial Information [Abstract]

SUPPLEMENTAL FINANCIAL INFORMATION

NOTE 4 - SUPPLEMENTAL FINANCIAL INFORMATION

Accrued Liabilities

Accrued liabilities consisted of the following:

	March 31, 2024		December 31, 2023
Accrued compensation	$	579,836	$	568,689
Accrued research and development expenses		988,826		-
Insurance premium financing		414,764		716,897
	$	1,983,426	$	1,285,586

In October 2023, the Company entered into a short-term note payable of $914,063 for the financing of insurance premiums. The note bears interest at 9.95% and monthly principal and interest payments of $105,819 are paid over a 9-month period. The Company recorded interest expense of $15,614 related to the short-term note payable during the three months ended March 31, 2024.